Editas Medicine (EDIT) Financials

$3.23

$0.15 (4.87%)

As on 04-Sep-2026 18:39EDT

Market cap

$496 Mln

Revenue (TTM)

$47 Mln

P/E Ratio

--

P/B Ratio

4.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	47.01	40.52	32.31	78.12	19.71	25.54
Cost of Revenue	21.06	5.28	199.25	6.06	6.34	5.05
Gross Profit	26.75	40.52	-166.93	72.06	19.71	25.54
Operating Expenses	108.87	139.86	84.22	241.24	245.66	218.69
Operating Profit (EBIT)	-82.12	-99.34	-251.15	-169.18	-225.95	-193.15
Other Income	--	--	--	--	5.52	0.64
Profit before Tax	-73.95	-160.06	-237.09	-153.22	-220.43	-192.50
Provision for Tax	--	--	--	5.90	-16.08	-7.40
Profit after Tax (Net Income)	-73.95	-160.06	-237.09	-153.22	-204.35	-185.11
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-220.43	-192.50

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	105.28	27.29	134.27	349.10	360.68	553.64
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	63.65	113.00	130.09	86.84	93.53	76.96
Current Liabilities	68.43	46.25	77.23	63.22	60.11	46.88
Total Liabilities	305.80	186.53	341.59	499.15	514.32	677.48

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	19.30	22.64	52.27	158.32	157.57	170.17
Current Assets	218.07	163.90	289.32	340.83	356.75	507.31
Total Assets	305.80	186.53	341.59	499.15	514.32	677.48
Total Debt*	15.51	76.71	35.03	48.54	43.95	26.38
Net Current Assets	149.63	117.65	212.09	277.61	296.64	460.43

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-165.24	-210.28	-132.18	-177.35	-163.80
Cash Flow from Investing Activities	--	138.67	162.15	-3.73	114.07	-54.47
Cash from Financing Activities	--	40.47	56.03	118.04	1.28	282.11
Net Cash Inflow / Outflow	--	--	--	--	-62.00	63.84

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.75	-1.80	-2.87	-1.88	-2.97	-2.71
Cash EPS ($)	--	-1.74	-2.80	-1.80	-2.88	-2.63
Adjusted Book Value ($)	--	0.31	1.63	4.27	5.24	8.10
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.86	-2.55	-1.62	-2.58	-2.40
Free Cash Flow per Share ($)	--	-1.87	-2.65	-1.68	-2.64	-2.51

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-117.13	-83.64	-38.20	-41.51	-37.03
ROE (%)	-111.56	-198.14	-98.10	-43.17	-44.70	-39.08
ROA (%)	-25.40	-60.61	-56.40	-30.24	-34.29	-29.62
EBIT Margin (%)	-154.56	-379.79	-739.37	-196.13	-1,146.26	-756.13
Net Margin (%)	-157.32	-395.01	-733.72	-196.13	-809.96	-706.84
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	20.83	0.25	-0.59	2.96	-0.23	-0.72
EBIT Growth (%)	67.21	35.59	-55.93	32.19	-16.98	-43.24
Net Profit Growth (%)	68.78	32.49	-54.74	25.02	-10.40	-69.18
EPS Growth (%)	73.67	0.37	-0.53	0.37	-0.10	-0.54
Book Value Growth (%)	288.22	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.14	-0.44	-5.40	-2.99	-9.80
Price / Book Value	4.49	6.67	0.78	2.37	1.69	3.28
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.36	-0.75	0.56	-3.76	-1.41	-7.13
Close Price ($)	3.24	2.05	1.27	10.13	8.87	26.55
High Price ($)	4.54	4.54	11.58	11.93	28.74	99.95
Low Price ($)	1.66	0.91	1.16	6.08	8.21	26.51
Market Cap ($ Cr)	496.06	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	2.81	0.26	0.14	0.12	0.05
Short term debt to equity ratio	0.06	0.40	0.11	0.07	0.03	0.02
Current Ratio	3.19	3.54	3.75	5.39	5.94	10.82
Quick Ratio	3.19	--	--	--	7.48	13.38
Interest Coverage	-5.62	-24.94	-109.10	--	-53.48	-33.90

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	5.80	37.45	50.34	13.04	26.10	1.05
Asset Turnover	0.16	0.15	0.08	0.15	0.03	0.04
Receivable days	--	141.71	149.50	35.84	50.14	45.15
Inventory Days	--	--	--	-5,607.47	-6,143.23	-8,303.02
Payable days	--	280.25	12.61	535.47	419.63	414.11
Cash Conversion Cycle	--	--	--	-6,107.09	-6,512.72	-8,671.99

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.